Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates (NCT02445040) | Clinical Trial Compass
UnknownNot Applicable
Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates
United States225 participantsStarted 2015-07
Plain-language summary
The purpose of this study is to determine the safety and effectiveness of the Babylog VN500 in high frequency oscillatory ventilation (HFOV) mode as a method for treating very low birth weight (VLBW) neonates requiring invasive respiratory support in the treatment of respiratory distress.
Who can participate
Age range23 Weeks – 30 Weeks
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Gestational Age between 23 to 30 weeks; within first 4 days of life
* very low birth weight between 400 g and 1200 g, inclusive
* 5-minute Apgar score \>3
* documented respiratory distress requiring invasive respiratory Support
* A priori: primary intention for either HFOV or high-frequency jet ventilation OR Severity of Illness: mechanical ventilation with a fraction of inspired oxygen of ≥ 0.25% and a mean airway pressure of ≥ 7 cm H2O, more than 2 hours after an initial dose of surfactant required and clinical care team believes that treatment with HFOV is indicated
* anticipated availability of investigational device at the study center before screening for enrollment
* written informed consent to participate in the study provided by a parent or legal guardian
Exclusion Criteria:
* anticipation to require intubation and mechanical ventilation for less than 12 hours
* previous exposure to any mechanical ventilation for ≥ 96 hours before planned HFOV treatment
* obvious chromosomal or major congenital abnormalities involving the respiratory tract or upper airway
* known congenital heart disease, excluding Patent Ductus Arteriosus (PDA), ventricular-septal defect, or atrial-septal defect
* pre-existing air leak, including pneumothorax, pneumomediastinum, pneumopericardium, or extensive bilateral Pulmonary Interstitial Emphysema (PIE)
* severe metabolic acidosis with a base deficit of ≥ 15 before planned HFOV treatment
* severe hypotension (a mean blo…
What they're measuring
1
Alive and free from Grade III/IV intraventricular hemorrhage (IVH) and cystic periventricular leukomalacia (PVL)